Category Archives: Drug use behaviours/harm reduction
Effective HIV prevention, education and outreach activities in African, Caribbean and Black communities
2014
Key take-home messages African, Caribbean and Black populations represent 14% of the HIV epidemic in Canada. To reduce new infections, HIV prevention intervention research is needed in these communities. Programs...
What is the effectiveness of supervised injection services?
2014
Key take-home messages The use of supervised injection services can lead to reductions in injecting behaviour and an increase in the number of clients accessing addiction treatment services. Supervised injection...
Crystal methamphetamine use, sexual risk behaviours and harm reduction among men who have sex with men
2015
Key take-home messages Use of crystal methamphetamine among men who have sex with men has been linked to unprotected sex, sex with multiple partners, sex with partners of unknown serostatus,...
HIV and STI testing among Indigenous women and women who inject drugs
2016
Key take-home messages Rates of HIV and other sexually transmitted and bloodborne infections are high among Indigenous women and women who inject drugs. For women who use drugs, centres that...
Chest compressions and rescue breathing when administering naloxone in opioid overdose
2016
Key take-home messages Opioid overdoses cause respiratory failure (a reduction or stop in breathing), which can lead to cardiac arrest. In the event of a suspected opioid overdose, bystanders should...
Engaging law enforcement in harm reduction programs for people who inject drugs
2016
Key take-home messages Injection drug use is a major contributor to the spread of HIV and Hepatitis C in Canada. Laws and policing practices that govern injection drug use influence...
Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review
2018
BACKGROUND: Injection drug use (IDU) in nonurban areas of the United States is a growing public health concern, but there has been no comprehensive assessment of existing research on injection-related...
Integrated models of care for individuals with opioid use disorder: How do we prevent HIV and HCV?
2018
PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care...
Sexualised drug use in the United Kingdom (UK): A review of the literature
2018
BACKGROUND: Sexualised drug use (SDU) refers to the use of drugs in a sexual context. This includes ‘Chemsex’- the use of drugs (specifically crystal methamphetamine, GHB/GBL and mephedrone) before or...
A scoping review of photovoice research among people with HIV
2018
We describe how Photovoice-a participatory method in which people express and share ideas via images-has been used in research with people living with HIV (PLWH). Four databases, reference lists, and...
Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact
2018
BACKGROUND: Needle and syringe program (NSP) service delivery models encompass fixed sites, mobile services, vending machines, pharmacies, peer NSPs, street outreach, and inter-organizational agreements to add NSP services to other...
HIV and viral hepatitis among imprisoned key populations
2018
Prisons and other closed facilities create opportunities for transmission of human immunodeficiency virus (HIV) and viral hepatitis during detention and after release. We conducted a systematic review and meta-analysis of...
